Literature DB >> 21411840

Neuroimmune mechanisms in functional bowel disorders.

M M Wouters1, G E Boeckxstaens.   

Abstract

The enteric nervous system regulates diverse functions including gastrointestinal motility and nociception. The sensory neurons detect mechanical and chemical stimuli while motor neurons control peristalsis and secretion. In addition to this extensive neuronal network, the gut also houses a highly specialised immune system which plays an important role in the induction and maintenance of tolerance to food and other luminal antigens and in the protection of the epithelial barrier against pathogenic invasion. It is now increasingly recognised that the gastrointestinal immune system and the enteric nervous system closely interact. This review will focus on two common functional gastrointestinal disorders in which neuroimmune interaction is involved in the pathophysiology: i.e. postoperative ileus and irritable bowel syndrome. Postoperative ileus arises after almost every abdominal surgical procedure. Handling of the bowel results in local inflammation and activation of inhibitory neuronal pathways resulting in a generalised impairment of gastrointestinal motor function or ileus. On the other hand, postinfectious irritable bowel syndrome (PI-IBS) occurs in 10 to 30% of patients who suffer from infectious gastroenteritis. PI -IBS patients develop abnormal gastrointestinal sensitivity, motility and secretion which contribute to abdominal pain and discomfort, bloating and abnormal bowel function (diarrhoea and/or constipation). Biopsy studies revealed persistent low-grade inflammation and altered immunological function which may lead to abnormal pain perception and motor activity within the gastrointestinal tract.

Entities:  

Mesh:

Year:  2011        PMID: 21411840

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  21 in total

1.  Evidence for neuronal and structural changes in submucous ganglia of patients with functional dyspepsia.

Authors:  Carla Cirillo; Talat Bessissow; An-Sofie Desmet; Hanne Vanheel; Jan Tack; Pieter Vanden Berghe
Journal:  Am J Gastroenterol       Date:  2015-06-16       Impact factor: 10.864

Review 2.  Immunopathological and molecular basis of functional dyspepsia and current therapeutic approaches.

Authors:  Mounika Addula; Victoria E D Wilson; Savio Reddymasu; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2018-09-29       Impact factor: 4.473

3.  The down-regulation of neuroligin-2 and the correlative clinical significance of serum GABA over-expression in Hirschsprung's disease.

Authors:  Hongchao Yang; Jianyi Niu; Jian Wang; Fan Zhang; Qiangye Zhang; Wentong Zhang; Aiwu Li
Journal:  Neurochem Res       Date:  2014-05-20       Impact factor: 3.996

Review 4.  Gastrointestinal motility disorders in inflammatory bowel diseases.

Authors:  Gabrio Bassotti; Elisabetta Antonelli; Vincenzo Villanacci; Marianna Salemme; Manuela Coppola; Vito Annese
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

5.  Abundance and significance of neuroligin-1 and glutamate in Hirschsprung's disease.

Authors:  Jian Wang; Hao Du; Ya-Ru Mou; Jian-Yi Niu; Wen-Tong Zhang; Hong-Chao Yang; Ai-Wu Li
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

6.  Endometriosis Is Associated With a Shift in MU Opioid and NMDA Receptor Expression in the Brain Periaqueductal Gray.

Authors:  Annelyn Torres-Reverón; Karylane Palermo; Anixa Hernández-López; Siomara Hernández; Myrella L Cruz; Kenira J Thompson; Idhaliz Flores; Caroline B Appleyard
Journal:  Reprod Sci       Date:  2016-04-18       Impact factor: 3.060

7.  Age-related symptom and life quality changes in women with irritable bowel syndrome.

Authors:  Yu-Rong Tang; Wei-Wei Yang; Mei-Lan Liang; Xin-Yu Xu; Mei-Feng Wang; Lin Lin
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

Review 8.  Abnormal gut motility in inflammatory bowel disease: an update.

Authors:  G Bassotti; E Antonelli; V Villanacci; R Nascimbeni; M P Dore; G M Pes; G Maconi
Journal:  Tech Coloproctol       Date:  2020-02-15       Impact factor: 3.781

Review 9.  Is irritable bowel syndrome an organic disorder?

Authors:  Magdy El-Salhy; Doris Gundersen; Odd Helge Gilja; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 10.  Refractory inflammatory bowel disease-could it be an irritable bowel?

Authors:  Jie Meng; Anurag Agrawal; Peter J Whorwell
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-09-11       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.